Stay updated with breaking news from Acip meeting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
to review documents for attorney/client privilege. is this sort of telling us what they re finding now? exactly. this is the status report of what that team this team, this filter team, that s what they re called, was involved with from the beginning when the search warrant was executed at mar-a-lago. former president trump s lawyers want a special master, an independent person to conduct the review. the judge told doj tell us what you ve done so far, it s been three weeks since you ve had these documents. that s what the new filing says, it s identified a limited set of materials that could possibly be covered by attorney/client privilege. they said they completed this review and have begun the process of going over anything where there could be a dispute. the search warrant lays out different ways that they were planning to handle a dispute, possibly going to the judge in private and saying, judge, do you think this could be covered by attorney/client privilege? s ....
I think they re basing it on what we do with influenza vaccines which is we have a lot of experience with the technology and so each new flu strain, each new flu vaccine is tailor made to the variants that are around at this time, and thinking that we have enough experience over decades to administer on a yearly basis without doing additional human testing. i understand that. my issue with mrna vaccines is still relatively new. we don t nearly have that wealth of experience. so i agree we absolutely need boosters, adults over the age of 50 will eventually need third boosters, we need fifth immunizations. those under 50 will need second immunizations as boosters. the question is whether we move forward with the original lineage or pair those together. that will be under discussion at the acip meeting at the cdc. yeah. and dr. paul affett on the fda ....
Merazzo, from the university of alabama birmingham. do you understand what the disconnect is? i wish i understood all of the details, but my take is this. we heard two and a half weeks ago from the white house in a very staged announcement, right? it was almost very theatrical that booster shots were going to be rolled out starting september 20th. and many people were rather surprised by that, including myself. first of all, because we really haven t seen all the data either from the pfizer vaccine or from israel, which is what the administration is apparently relying on a lot. second of all, that timeline would impose an incredible burden on both the fda and acip, the cdc s arm for discussing immunizations, to make it happen by then. and we know from the acip meeting that happened a few days ago that people are really ....
Four weeks apart because we were in crisis, we were losing 3,000 american lives a day, we had to get everybody fully vaccinated. but when you do that kind of schedule, it almost guarantees that you will have waning immunity at some point. and that s the reason why it became a three-dose vaccine. the other piece, though, is we haven t seen whether we re really seeing breakthrough hospitalizations. yet we are seeing a lot of breakthrough infections, efficacy s declining from over 90% to 40 to 50%. do we need to see that decline in hospitalizations as well? or because of the longhaul covid that we are seeing among breakthrough unvaccinated cases. so the acip which met today only set aside a small amount of time for these questions. pfizer s just recently applied for it. so i think this will come up at the next acip meeting. pfizer today indicated that it will submit vaccine data for children ages 5 to 11 in ....
Emergency use authorizations will only apply to those mnra vaccines, pfizer and moderna. okay. what are you supposed to do, erica, if you got a j&j vaccine? it s all about asking your doctor. and administration, the federal officials said certainly people can mix and match doses. however, all of this has to go through the fda regulation, the acip meeting as monica said has to happen tomorrow, the cdc has to officially recommend this booster shot for this particular population. that s when they can actually get this shot and talk to their doctors about what is really appropriate for them and an extra dose is only going to be limited to the pfizer and moderna shots. so erica, why can we get a fast track fda approval of a third does but we can t seem to get full authorization for the first dose? ....